Journal article · 2012 · Open access
Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity
Journal of Dermatological Treatment, 24(5), 356–360 · Published 8 December 2012 · DOI 10.3109/09546634.2012.742950
In brief
“Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity” is a 2012 journal article by Donald M. Bushnell and 7 co-authors, published in Journal of Dermatological Treatment. OpenAlex counts 69 citations as of 22 November 2026. It is open access: the full text is free to read at Journal of Dermatological Treatment.
- Citations
- 69
- Most cited in
- 2017 (12)
- Field-weighted impact
- 1.89
- References
- 10
- Authors
- 8
Abstract
BACKGROUND: The objective of this study was to evaluate the measurement properties of the Psoriasis Symptom Inventory (PSI), an eight-item patient-reported outcome measure for assessing severity of plaque psoriasis symptoms. METHODS: In this prospective, randomized study using data from adults with moderate-to-severe plaque psoriasis, patients completed the PSI, Dermatology Life Quality Index (DLQI), SF-36v2 Acute, and Patient Global Assessment (PtGA). PSI construct validity was assessed using Spearman rank correlations between PSI and DLQI and SF-36; test-retest reliability and sensitivity to change were evaluated using PtGA as an anchor. Daily 24-h and weekly 7-day PSI versions were evaluated. RESULTS: Eight US sites enrolled 143 patients; 139 (97.2%) completed the study. All symptoms (itch, redness, scaling, burning, cracking, stinging, flaking, and pain) were reported across all response options (not at all severe, mild, moderate, severe, very severe). Test-retest reliability was acceptable (intraclass correlation coefficients range = 0.70-0.80). A priori hypotheses of convergent and discriminant validity were confirmed by correlations of PSI with DLQI items and SF-36 domains. The PSI demonstrated good construct validity and was sensitive to within-subject change (p < 0.0001). CONCLUSIONS: The PSI is brief, valid, reproducible, and responsive to change and has the potential to be a useful PRO measure in psoriasis clinical trials.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Bushnell, D. M., Martin, M. L., McCarrier, K. P., Gordon, K. B., Chiou, C., Huang, X., Ortmeier, B. G., & Kricorian, G. (2012). Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity. Journal of Dermatological Treatment, 24(5), 356–360. https://doi.org/10.3109/09546634.2012.742950
MLA 9
Bushnell, Donald M., et al. “Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity.” Journal of Dermatological Treatment, vol. 24, no. 5, 2012, pp. 356–360. https://doi.org/10.3109/09546634.2012.742950.
Chicago
Bushnell, Donald M., Mona L. Martin, Kelly P. McCarrier, Kenneth B. Gordon, Chiun‐Fang Chiou, Xingyue Huang, Brian G. Ortmeier, and Gregory Kricorian. 2012. “Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity.” Journal of Dermatological Treatment 24 (5): 356–360. https://doi.org/10.3109/09546634.2012.742950.
Harvard
Bushnell, D. M. et al. (2012) ‘Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity’, Journal of Dermatological Treatment, 24(5), pp. 356–360. doi:10.3109/09546634.2012.742950.
IEEE
D. M. Bushnell et al., “Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity,” Journal of Dermatological Treatment, vol. 24, no. 5, pp. 356–360, 2012, doi: 10.3109/09546634.2012.742950.
BibTeX
@article{bushnell2012validation,
title = {{Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity}},
author = {Bushnell, Donald M. and Martin, Mona L. and McCarrier, Kelly P. and Gordon, Kenneth B. and Chiou, Chiun‐Fang and Huang, Xingyue and Ortmeier, Brian G. and Kricorian, Gregory},
journal = {Journal of Dermatological Treatment},
year = {2012},
volume = {24},
number = {5},
pages = {356--360},
doi = {10.3109/09546634.2012.742950},
url = {https://doi.org/10.3109/09546634.2012.742950}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 12 | |
| 2018 | 6 | |
| 2019 | 5 | |
| 2020 | 6 | |
| 2021 | 3 | |
| 2022 | 4 | |
| 2023 | 1 | |
| 2024 | 4 | |
| 2025 | 2 | |
| 2026 | 2 |
Its field-weighted citation impact is 1.89: it has been cited 1.89 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- plaque psoriasis
- symptom severity
- patient-reported outcome measures
- construct validity
- test-retest reliability
- sensitivity to change
- Dermatology Life Quality Index
- SF-36
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Bushnell, D. M., Martin, M. L., McCarrier, K. P., Gordon, K. B., Chiou, C., Huang, X., Ortmeier, B. G., & Kricorian, G. (2012). Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity. Journal of Dermatological Treatment, 24(5), 356–360. https://doi.org/10.3109/09546634.2012.742950
How many times has this paper been cited?
69 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Dermatological Treatment: sign in and open the PDF from this page.
Who wrote this paper?
Donald M. Bushnell, Mona L. Martin, Kelly P. McCarrier, Kenneth B. Gordon, Chiun‐Fang Chiou, Xingyue Huang, Brian G. Ortmeier, Gregory Kricorian.
What is the DOI of this paper?
10.3109/09546634.2012.742950, permanently at https://doi.org/10.3109/09546634.2012.742950. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.